Követés
Martin L Miller
Martin L Miller
Senior Director, AstraZeneca
E-mail megerősítve itt: astrazeneca.com
Cím
Hivatkozott rá
Hivatkozott rá
Év
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
NA Rizvi, MD Hellmann, A Snyder, P Kvistborg, V Makarov, JJ Havel, ...
Science 348 (6230), 124-128, 2015
85442015
The cancer genome atlas pan-cancer analysis project
JN Weinstein, EA Collisson, GB Mills, KR Shaw, BA Ozenberger, K Ellrott, ...
Nature genetics 45 (10), 1113-1120, 2013
74082013
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ...
Cell 161 (7), 1681-1696, 2015
29392015
Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis
MM Jesper V Olsen, Michiel Vermeulen, Anna Santamaria, Chanchal Kumar ...
Science Signaling, 2010
17622010
Emerging landscape of oncogenic signatures across human cancers
G Ciriello, ML Miller, BA Aksoy, Y Senbabaoglu, N Schultz, C Sander
Nature genetics 45 (10), 1127-1133, 2013
15882013
Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs
AA Khan, D Betel, ML Miller, C Sander, CS Leslie, DS Marks
Nature biotechnology 27 (6), 549-555, 2009
6752009
Linear motif atlas for phosphorylation-dependent signaling.
ML Miller, LJ Jensen, F Diella, C Jørgensen, M Tinti, L Li, M Hsiung, ...
Science signaling 1 (35), ra2, 2008
5322008
Mitochondrial DNA copy number variation across human cancers
E Reznik, ML Miller, Y Şenbabaoğlu, N Riaz, J Sarungbam, SK Tickoo, ...
elife 5, e10769, 2016
4882016
Heterogeneous tumor-immune microenvironments among differentially growing metastases in an ovarian cancer patient
A Jiménez-Sánchez, D Memon, S Pourpe, H Veeraraghavan, Y Li, ...
Cell 170 (5), 927-938. e20, 2017
4832017
KinomeXplorer: an integrated platform for kinome biology studies
H Horn, EM Schoof, J Kim, X Robin, ML Miller, F Diella, A Palma, ...
Nature methods 11 (6), 603-604, 2014
3792014
UVB-induced tumor heterogeneity diminishes immune response in melanoma
Y Wolf, O Bartok, S Patkar, GB Eli, S Cohen, K Litchfield, R Levy, ...
Cell 179 (1), 219-235. e21, 2019
3772019
Promises and challenges of adoptive T-cell therapies for solid tumours
M Morotti, A Albukhari, A Alsaadi, M Artibani, JD Brenton, SM Curbishley, ...
British journal of cancer 124 (11), 1759-1776, 2021
2282021
Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy
A Jiménez-Sánchez, P Cybulska, KLV Mager, S Koplev, O Cast, ...
Nature Genetics 52 (6), 582-593, 2020
1992020
Perturbation biology: inferring signaling networks in cellular systems
EJ Molinelli, A Korkut, W Wang, ML Miller, NP Gauthier, X Jing, P Kaushik, ...
PLoS computational biology 9 (12), e1003290, 2013
1792013
NetPhosYeast: prediction of protein phosphorylation sites in yeast
CR Ingrell, ML Miller, ON Jensen, N Blom
Bioinformatics 23 (7), 895-897, 2007
1642007
Comprehensive benchmarking and integration of tumor microenvironment cell estimation methods
A Jiménez-Sánchez, O Cast, ML Miller
Cancer Research 79 (24), 6238-6246, 2019
1572019
The SH2 domain interaction landscape
M Tinti, L Kiemer, S Costa, ML Miller, F Sacco, JV Olsen, M Carducci, ...
Cell reports 3 (4), 1293-1305, 2013
1322013
Pan-cancer analysis of mutation hotspots in protein domains
ML Miller, E Reznik, NP Gauthier, BA Aksoy, A Korkut, J Gao, G Ciriello, ...
Cell systems 1 (3), 197-209, 2015
1262015
Drug synergy screen and network modeling in dedifferentiated liposarcoma identifies CDK4 and IGF1R as synergistic drug targets
ML Miller, EJ Molinelli, JS Nair, T Sheikh, R Samy, X Jing, Q He, A Korkut, ...
Science signaling 6 (294), ra85-ra85, 2013
1002013
NetPhosBac–a predictor for Ser/Thr phosphorylation sites in bacterial proteins
ML Miller, B Soufi, C Jers, N Blom, B Macek, I Mijakovic
Proteomics 9 (1), 116-125, 2009
902009
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20